Global Attention Deficit Hyperactivity Disorder Market Size, Share & Industry Trends Analysis Report By Drug Type, By Demographics (Adults and Children), By Distribution Channel (Retail Pharmacy and Hospital Pharmacy), By Regional Outlook and Forecast, 2022 - 2028

The Global Attention Deficit Hyperactivity Disorder Market size is expected to reach $16.9 billion by 2028, rising at a market growth of 4.0% CAGR during the forecast period.

Attention deficit hyperactivity disorder, or ADHD, is a common psychiatric disorder that starts during childhood. This widespread neurodevelopmental disorder is typically identified for the first time in childhood and frequently persists into maturity. Children with ADHD might struggle to focus, manage impulsive behaviors (doing without considering the consequences), or be highly active. This disorder is also called as hyperkinetic disorder (HKD).

It is normal for kids to struggle with their manners and attention spans occasionally. The symptoms persist, can be unpleasant, and make it difficult to interact with friends, family, or co-workers. As a significant public health issue, ADHD has been linked to a wide range of adverse health outcomes for those affected and considerable cost burdens for their families and societies at large.

As a result, children's ADHD prevalence has come under scrutiny, and understanding it is essential for future service planning, training, resource allocation, and research goals. According to several reviews, prevalence rates among adolescents and children worldwide ranged widely, from as low as almost 1% to as significant as over 20%.

The most widely used criteria for ADHD are those found in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) published by the American Psychiatric Association. These criteria divide ADHD into three subtypes based on the predominating symptom pattern: hyperactive-impulsive type, inattentive type, and combined type. The DSM-IV diagnosis of ADHD also allows for the occurrence of frequent co-occurring disorders like anxiety or depression.

COVID-19 Impact Analysis

Given their susceptibility to the discomfort caused by the lockdown measures and social distancing measures, people with ADHD had a terrible experience during the pandemic. These interventions caused people with ADHD to display more behavioral issues. The prevalence of symptoms increased the discomfort for the patient as well as their families. Additionally, market players had to utilize novel medicines because necessary drugs ran out of supply due to consumers’ action of panic buying necessities as a precaution. This also applied to the treatments for ADHD.

Market Growth Factors

Enabling the disorder sufferer to build self-esteem and self-awareness

When ADHD is left untreated, it severely threatens the patient's well-being. As a result, the development of anxiety, depression, and bipolar disorder increases. Consequently, this also makes the situation hard for those directly involved with the sufferers. In addition, the mounting disappointments and frustrations can further accelerate the chances of forming antisocial personality disorder.

Increasing recognition of behavioral therapy benefits

Although there are two significant ways to treat ADHD, combining the two frequently yields the best outcomes. Therefore, medication combined with behavioral therapy provides better control of the treatment of ADHD. Recently, behavioral therapies have gained significant attention from parents who have children with ADHD. Parents and kids in this situation attend specialist lessons to manage and reduce the consequences of ADHD.

Marketing Restraining Factor

Prominent side-effects of medications

While the number of studies is being conducted on the curative measurements of ADHD symptoms, nothing highly effective has been found. Furthermore, the available data from previous studies lack sufficient approval for the formulas to be developed. The available medicines for ADHD, hence, are only able to treat either a specific patient group or only some symptoms. In addition, these medications do not work the same and, therefore, deliver side effects. From the collected data, it has also been found that the prominence of side effects is also highly unexpected.

Drug Type Outlook

Based on drug type, the attention deficit hyperactivity disorder market is categorized into stimulants and non-stimulants. The stimulants segment procured the highest revenue share in the attention deficit hyperactivity disorder market in 2021. These are the most frequently prescribed drugs for attention deficit hyperactivity disorder. These drugs may aid in maintaining mental focus and ignoring distractions. Most patients with ADHD have reported success with stimulant medications. These are usually prescribed for the treatment of severe and moderate ADHD. They might be helpful for kids, adolescents, and adults who struggle at school, home, or work.

Stimulants Outlook

The stimulants segment is further divided into amphetamine, methylphenidate, lisdexamfetamine, dexmethylphenidate. The amphetamine segment witnessed the largest revenue share in the attention deficit hyperactivity disorder market in 2021. Amphetamine or dextroamphetamine are potent central nervous system (CNS) stimulants. These drugs indirectly act as sympathomimetic amines and are also used for treating narcolepsy and hyperactivity other than ADHD. This class of drugs increases the focus on any activity, raises the ability to pay attention, and also assists in controlling impulsive behavioral symptoms.

Non- Stimulants Outlook

The non-stimulants segment is further classified into atomoxetine, guanfacine, clonidine, and others. The atomoxetine segment acquired the maximum revenue share in the attention deficit hyperactivity disorder market in 2021. Compared to other ADHD medications, atomoxetine operates differently. Atomoxetine is a selective noradrenaline reuptake inhibitor (SNRI), and hence it raises the levels of noradrenaline, which transports messages across brain cells, in the brain. By boosting this neurotransmitter, people with ADHD are able to improve focus and impulse control.

Demographics Outlook

On the basis of demographics, the attention deficit hyperactivity disorder market is fragmented into children (2 to 17 years of age) and adults. The children segment witnessed a substantial revenue share in the attention deficit hyperactivity disorder market in 2021. Children with ADHD find it challenging to control their impulsive behaviors, which can include anything from speech to movement to concentration. As a result, these kids are occasionally referred to as troublemakers or chastised for their laziness and lack of discipline.

Distribution Channel Outlook

Based on distribution channel, the attention deficit hyperactivity disorder market is segmented into retail pharmacy and hospital pharmacy. The retail pharmacy segment recorded the largest revenue share in the attention deficit hyperactivity disorder market in 2021. The majority of ADHD patients receive their care in outpatient settings, which has mainly given the segment its growth. Increased attention is also being paid to patient care initiatives to offer patients personal Electronic Health Records (EHRs) to keep track of their medical histories and receive primary care.

Attention Deficit Hyperactivity Disorder Market Report Coverage

Report Attribute	Details
Market size value in 2021	USD 12.9 Billion
Market size forecast in 2028	USD 16.9 Billion
Base Year	2021
Historical Period	2018 to 2020
Forecast Period	2022 to 2028
Revenue Growth Rate	CAGR of 4% from 2022 to 2028
Number of Pages	294
Number of Tables	520
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered	Drug Type, Demographics, Distribution Channel, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Enabling the disorder sufferer to build self-esteem and self-awareness Increasing recognition of behavioral therapy benefits
Restraints	Prominent side-effects of medications

Regional Outlook

On the basis of region, the attention deficit hyperactivity disorder market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the maximum revenue share in the attention deficit hyperactivity disorder market in 2021. The widespread introduction and quick acceptance of various ADHD medications are the primary factors influencing the segment's growth. Growth is further anticipated by better patient affordability, favorable reimbursement policies, and rising public awareness of current treatment modalities.

Free Valuable Insights: Global Attention Deficit Hyperactivity Disorder Market size to reach USD 16.9 Billion by 2028

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Eli Lilly And Company, Pfizer, Inc. (Global Blood Therapeutics, Inc.), Johnson & Johnson (Johnson & Johnson Services, Inc.), Lupin Limited, Novartis AG, Takeda Pharmaceutical Company Limited, Mallinckrodt PLC, Purdue Pharma L.P., Aytu BioPharma, Inc. and Supernus Pharmaceuticals, Inc.

Strategies deployed in Attention Deficit Hyperactivity Disorder Market

• Jan-2022: Eli Lilly and Company completed the acquisition of Prevail Therapeutics Inc., a gene therapy company. This acquisition forms a new manner for drug discovery and development at Lilly, broadening Lilly's research efforts through the creation of a gene therapy program that would be strengthened by Prevail's offerings of preclinical and clinical neuroscience assets.
• Jul-2021: Eli Lilly and Company took over Protomer Technologies, a private biotech company. Under this acquisition, Protomer's glucose-sensing insulin program based on its proprietary molecular engineering of protein sensors (MEPS) platform is showing better results and Lilly would increase its diabetes portfolio with Lilly's innovative technology.
• Jul-2021: Adlon Therapeutics L.P., a subsidiary of Purdue Pharma L.P., received FDA approval for a supplemental New Drug Application (sNDA) to modify the prescribing details for Adhansia XR® (methylphenidate hydrochloride) extended-release capsules CII. The sNDA approval was based on data from a Phase 3 Adult Laboratory Classroom (ALC), placebo-controlled, parallel-group, randomized, double-blind study analyzing the safety and accuracy of Adhansia XR in adult patients diagnosed with ADHD.
• Apr-2021: Supernus Pharmaceuticals, Inc. received FDA approval for Qelbree, viloxazine extended-release capsules. The product treats attention-deficit hyperactivity disorder (ADHD) in pediatric patients 6 to 17 years of age. Qelbree serves prescribing physicians and patients living with ADHD a therapy that is not a controlled substance with proven efficacy and a tolerable safety profile.
• Mar-2019: Novartis received FDA approval for Mayzent, a medicine for the treatment of adults with relapsing forms of multiple sclerosis consisting of relapsing-remitting multiple sclerosis, clinically isolated syndrome, and secondary progressive multiple sclerosis (SPMS) with active disease. The Product hinders disability progression and preserving cognition.
• Oct-2018: Neos Therapeutics, Inc., merged with Aytu BioPharma, Inc. got FDA approval for Cotempla XR-ODT, the first methylphenidate extended-release orally disintegrating tablet. The product treats attention-deficit/hyperactivity disorder (ADHD) in patients within the age group of 6 to 17 years old.
• May-2018: Novartis received FDA approval for Aimovig, a prescription medicine used for the preventive treatment of migraine in adults. The product is a novel therapeutic approach as one of the FDA-approved treatments mainly developed to stop migraine by blocking the calcitonin gene-related peptide receptor (CGRP-R) that plays a major role in migraine.
• Feb-2018: Neos Therapeutics, Inc., merged with Aytu BioPharma, Inc. announced the launch of Adzenys ERTM Extended-Release Oral Suspension, creating Neos’ third ADHD product. Neos Therapeutics, Inc.'s increasing ADHD Product offerings show the strength of the company's technology platform and Neos Therapeutics capability to develop, manufacture, and commercialize products.

Scope of the Study

Market Segments Covered in the Report:

By Drug Type

• Stimulants
  • Amphetamine
  • Methylphenidate
  • Lisdexamfetamine
  • Dexmethylphenidate
• Non-stimulants
  • Atomoxetine
  • Guanfacine
  • Clonidine
  • Others

By Demographics

• Adults
• Children

By Distribution Channel

• Retail Pharmacy
• Hospital Pharmacy

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Eli Lilly And Company
• Pfizer, Inc. (Global Blood Therapeutics, Inc.)
• Johnson & Johnson (Johnson & Johnson Services, Inc.)
• Lupin Limited
• Novartis AG
• Takeda Pharmaceutical Company Limited
• Mallinckrodt PLC
• Purdue Pharma L.P.
• Aytu BioPharma, Inc.
• Supernus Pharmaceuticals, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Attention Deficit Hyperactivity Disorder Market, by Drug Type
1.4.2 Global Attention Deficit Hyperactivity Disorder Market, by Demographics
1.4.3 Global Attention Deficit Hyperactivity Disorder Market, by Distribution Channel
1.4.4 Global Attention Deficit Hyperactivity Disorder Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Attention Deficit Hyperactivity Disorder Market

Chapter 4. Global Attention Deficit Hyperactivity Disorder Market by Drug Type
4.1 Global Stimulants Market by Region
4.2 Global Attention Deficit Hyperactivity Disorder Market by Stimulants Type
4.2.1 Global Amphetamine Market by Region
4.2.2 Global Methylphenidate Market by Region
4.2.3 Global Lisdexamfetamine Market by Region
4.2.4 Global Dexmethylphenidate Market by Region
4.3 Global Non-stimulants Market by Region
4.4 Global Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
4.4.1 Global Atomoxetine Market by Region
4.4.2 Global Guanfacine Market by Region
4.4.3 Global Clonidine Market by Region
4.4.4 Global Others Market by Region

Chapter 5. Global Attention Deficit Hyperactivity Disorder Market by Demographics
5.1 Global Adults Market by Region
5.2 Global Children Market by Region

Chapter 6. Global Attention Deficit Hyperactivity Disorder Market by Distribution Channel
6.1 Global Retail Pharmacy Market by Region
6.2 Global Hospital Pharmacy Market by Region

Chapter 7. Global Attention Deficit Hyperactivity Disorder Market by Region
7.1 North America Attention Deficit Hyperactivity Disorder Market
7.1.1 North America Attention Deficit Hyperactivity Disorder Market by Drug Type
7.1.1.1 North America Stimulants Market by Country
7.1.1.2 North America Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.1.1.2.1 North America Amphetamine Market by Country
7.1.1.2.2 North America Methylphenidate Market by Country
7.1.1.2.3 North America Lisdexamfetamine Market by Country
7.1.1.2.4 North America Dexmethylphenidate Market by Country
7.1.1.3 North America Non-stimulants Market by Country
7.1.1.4 North America Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.1.1.4.1 North America Atomoxetine Market by Country
7.1.1.4.2 North America Guanfacine Market by Country
7.1.1.4.3 North America Clonidine Market by Country
7.1.1.4.4 North America Others Market by Country
7.1.2 North America Attention Deficit Hyperactivity Disorder Market by Demographics
7.1.2.1 North America Adults Market by Country
7.1.2.2 North America Children Market by Country
7.1.3 North America Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.1.3.1 North America Retail Pharmacy Market by Country
7.1.3.2 North America Hospital Pharmacy Market by Country
7.1.4 North America Attention Deficit Hyperactivity Disorder Market by Country
7.1.4.1 US Attention Deficit Hyperactivity Disorder Market
7.1.4.1.1 US Attention Deficit Hyperactivity Disorder Market by Drug Type
7.1.4.1.1.1 US Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.1.4.1.1.2 US Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.1.4.1.2 US Attention Deficit Hyperactivity Disorder Market by Demographics
7.1.4.1.3 US Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.1.4.2 Canada Attention Deficit Hyperactivity Disorder Market
7.1.4.2.1 Canada Attention Deficit Hyperactivity Disorder Market by Drug Type
7.1.4.2.1.1 Canada Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.1.4.2.1.2 Canada Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.1.4.2.2 Canada Attention Deficit Hyperactivity Disorder Market by Demographics
7.1.4.2.3 Canada Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.1.4.3 Mexico Attention Deficit Hyperactivity Disorder Market
7.1.4.3.1 Mexico Attention Deficit Hyperactivity Disorder Market by Drug Type
7.1.4.3.1.1 Mexico Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.1.4.3.1.2 Mexico Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.1.4.3.2 Mexico Attention Deficit Hyperactivity Disorder Market by Demographics
7.1.4.3.3 Mexico Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.1.4.4 Rest of North America Attention Deficit Hyperactivity Disorder Market
7.1.4.4.1 Rest of North America Attention Deficit Hyperactivity Disorder Market by Drug Type
7.1.4.4.1.1 Rest of North America Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.1.4.4.1.2 Rest of North America Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.1.4.4.2 Rest of North America Attention Deficit Hyperactivity Disorder Market by Demographics
7.1.4.4.3 Rest of North America Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.2 Europe Attention Deficit Hyperactivity Disorder Market
7.2.1 Europe Attention Deficit Hyperactivity Disorder Market by Drug Type
7.2.1.1 Europe Stimulants Market by Country
7.2.1.2 Europe Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.2.1.2.1 Europe Amphetamine Market by Country
7.2.1.2.2 Europe Methylphenidate Market by Country
7.2.1.2.3 Europe Lisdexamfetamine Market by Country
7.2.1.2.4 Europe Dexmethylphenidate Market by Country
7.2.1.3 Europe Non-stimulants Market by Country
7.2.1.4 Europe Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.2.1.4.1 Europe Atomoxetine Market by Country
7.2.1.4.2 Europe Guanfacine Market by Country
7.2.1.4.3 Europe Clonidine Market by Country
7.2.1.4.4 Europe Others Market by Country
7.2.2 Europe Attention Deficit Hyperactivity Disorder Market by Demographics
7.2.2.1 Europe Adults Market by Country
7.2.2.2 Europe Children Market by Country
7.2.3 Europe Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.2.3.1 Europe Retail Pharmacy Market by Country
7.2.3.2 Europe Hospital Pharmacy Market by Country
7.2.4 Europe Attention Deficit Hyperactivity Disorder Market by Country
7.2.4.1 Germany Attention Deficit Hyperactivity Disorder Market
7.2.4.1.1 Germany Attention Deficit Hyperactivity Disorder Market by Drug Type
7.2.4.1.1.1 Germany Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.2.4.1.1.2 Germany Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.2.4.1.2 Germany Attention Deficit Hyperactivity Disorder Market by Demographics
7.2.4.1.3 Germany Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.2.4.2 UK Attention Deficit Hyperactivity Disorder Market
7.2.4.2.1 UK Attention Deficit Hyperactivity Disorder Market by Drug Type
7.2.4.2.1.1 UK Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.2.4.2.1.2 UK Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.2.4.2.2 UK Attention Deficit Hyperactivity Disorder Market by Demographics
7.2.4.2.3 UK Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.2.4.3 France Attention Deficit Hyperactivity Disorder Market
7.2.4.3.1 France Attention Deficit Hyperactivity Disorder Market by Drug Type
7.2.4.3.1.1 France Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.2.4.3.1.2 France Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.2.4.3.2 France Attention Deficit Hyperactivity Disorder Market by Demographics
7.2.4.3.3 France Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.2.4.4 Russia Attention Deficit Hyperactivity Disorder Market
7.2.4.4.1 Russia Attention Deficit Hyperactivity Disorder Market by Drug Type
7.2.4.4.1.1 Russia Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.2.4.4.1.2 Russia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.2.4.4.2 Russia Attention Deficit Hyperactivity Disorder Market by Demographics
7.2.4.4.3 Russia Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.2.4.5 Spain Attention Deficit Hyperactivity Disorder Market
7.2.4.5.1 Spain Attention Deficit Hyperactivity Disorder Market by Drug Type
7.2.4.5.1.1 Spain Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.2.4.5.1.2 Spain Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.2.4.5.2 Spain Attention Deficit Hyperactivity Disorder Market by Demographics
7.2.4.5.3 Spain Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.2.4.6 Italy Attention Deficit Hyperactivity Disorder Market
7.2.4.6.1 Italy Attention Deficit Hyperactivity Disorder Market by Drug Type
7.2.4.6.1.1 Italy Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.2.4.6.1.2 Italy Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.2.4.6.2 Italy Attention Deficit Hyperactivity Disorder Market by Demographics
7.2.4.6.3 Italy Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.2.4.7 Rest of Europe Attention Deficit Hyperactivity Disorder Market
7.2.4.7.1 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Drug Type
7.2.4.7.1.1 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.2.4.7.1.2 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.2.4.7.2 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Demographics
7.2.4.7.3 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.3 Asia Pacific Attention Deficit Hyperactivity Disorder Market
7.3.1 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Drug Type
7.3.1.1 Asia Pacific Stimulants Market by Country
7.3.1.2 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.3.1.2.1 Asia Pacific Amphetamine Market by Country
7.3.1.2.2 Asia Pacific Methylphenidate Market by Country
7.3.1.2.3 Asia Pacific Lisdexamfetamine Market by Country
7.3.1.2.4 Asia Pacific Dexmethylphenidate Market by Country
7.3.1.3 Asia Pacific Non-stimulants Market by Country
7.3.1.4 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.3.1.4.1 Asia Pacific Atomoxetine Market by Country
7.3.1.4.2 Asia Pacific Guanfacine Market by Country
7.3.1.4.3 Asia Pacific Clonidine Market by Country
7.3.1.4.4 Asia Pacific Others Market by Country
7.3.2 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Demographics
7.3.2.1 Asia Pacific Adults Market by Country
7.3.2.2 Asia Pacific Children Market by Country
7.3.3 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.3.3.1 Asia Pacific Retail Pharmacy Market by Country
7.3.3.2 Asia Pacific Hospital Pharmacy Market by Country
7.3.4 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Country
7.3.4.1 China Attention Deficit Hyperactivity Disorder Market
7.3.4.1.1 China Attention Deficit Hyperactivity Disorder Market by Drug Type
7.3.4.1.1.1 China Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.3.4.1.1.2 China Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.3.4.1.2 China Attention Deficit Hyperactivity Disorder Market by Demographics
7.3.4.1.3 China Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.3.4.2 Japan Attention Deficit Hyperactivity Disorder Market
7.3.4.2.1 Japan Attention Deficit Hyperactivity Disorder Market by Drug Type
7.3.4.2.1.1 Japan Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.3.4.2.1.2 Japan Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.3.4.2.2 Japan Attention Deficit Hyperactivity Disorder Market by Demographics
7.3.4.2.3 Japan Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.3.4.3 India Attention Deficit Hyperactivity Disorder Market
7.3.4.3.1 India Attention Deficit Hyperactivity Disorder Market by Drug Type
7.3.4.3.1.1 India Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.3.4.3.1.2 India Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.3.4.3.2 India Attention Deficit Hyperactivity Disorder Market by Demographics
7.3.4.3.3 India Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.3.4.4 South Korea Attention Deficit Hyperactivity Disorder Market
7.3.4.4.1 South Korea Attention Deficit Hyperactivity Disorder Market by Drug Type
7.3.4.4.1.1 South Korea Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.3.4.4.1.2 South Korea Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.3.4.4.2 South Korea Attention Deficit Hyperactivity Disorder Market by Demographics
7.3.4.4.3 South Korea Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.3.4.5 Singapore Attention Deficit Hyperactivity Disorder Market
7.3.4.5.1 Singapore Attention Deficit Hyperactivity Disorder Market by Drug Type
7.3.4.5.1.1 Singapore Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.3.4.5.1.2 Singapore Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.3.4.5.2 Singapore Attention Deficit Hyperactivity Disorder Market by Demographics
7.3.4.5.3 Singapore Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.3.4.6 Malaysia Attention Deficit Hyperactivity Disorder Market
7.3.4.6.1 Malaysia Attention Deficit Hyperactivity Disorder Market by Drug Type
7.3.4.6.1.1 Malaysia Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.3.4.6.1.2 Malaysia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.3.4.6.2 Malaysia Attention Deficit Hyperactivity Disorder Market by Demographics
7.3.4.6.3 Malaysia Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.3.4.7 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market
7.3.4.7.1 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Drug Type
7.3.4.7.1.1 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.3.4.7.1.2 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.3.4.7.2 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Demographics
7.3.4.7.3 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.4 LAMEA Attention Deficit Hyperactivity Disorder Market
7.4.1 LAMEA Attention Deficit Hyperactivity Disorder Market by Drug Type
7.4.1.1 LAMEA Stimulants Market by Country
7.4.1.2 LAMEA Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.4.1.2.1 LAMEA Amphetamine Market by Country
7.4.1.2.2 LAMEA Methylphenidate Market by Country
7.4.1.2.3 LAMEA Lisdexamfetamine Market by Country
7.4.1.2.4 LAMEA Dexmethylphenidate Market by Country
7.4.1.3 LAMEA Non-stimulants Market by Country
7.4.1.4 LAMEA Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.4.1.4.1 LAMEA Atomoxetine Market by Country
7.4.1.4.2 LAMEA Guanfacine Market by Country
7.4.1.4.3 LAMEA Clonidine Market by Country
7.4.1.4.4 LAMEA Others Market by Country
7.4.2 LAMEA Attention Deficit Hyperactivity Disorder Market by Demographics
7.4.2.1 LAMEA Adults Market by Country
7.4.2.2 LAMEA Children Market by Country
7.4.3 LAMEA Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.4.3.1 LAMEA Retail Pharmacy Market by Country
7.4.3.2 LAMEA Hospital Pharmacy Market by Country
7.4.4 LAMEA Attention Deficit Hyperactivity Disorder Market by Country
7.4.4.1 Brazil Attention Deficit Hyperactivity Disorder Market
7.4.4.1.1 Brazil Attention Deficit Hyperactivity Disorder Market by Drug Type
7.4.4.1.1.1 Brazil Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.4.4.1.1.2 Brazil Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.4.4.1.2 Brazil Attention Deficit Hyperactivity Disorder Market by Demographics
7.4.4.1.3 Brazil Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.4.4.2 Argentina Attention Deficit Hyperactivity Disorder Market
7.4.4.2.1 Argentina Attention Deficit Hyperactivity Disorder Market by Drug Type
7.4.4.2.1.1 Argentina Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.4.4.2.1.2 Argentina Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.4.4.2.2 Argentina Attention Deficit Hyperactivity Disorder Market by Demographics
7.4.4.2.3 Argentina Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.4.4.3 UAE Attention Deficit Hyperactivity Disorder Market
7.4.4.3.1 UAE Attention Deficit Hyperactivity Disorder Market by Drug Type
7.4.4.3.1.1 UAE Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.4.4.3.1.2 UAE Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.4.4.3.2 UAE Attention Deficit Hyperactivity Disorder Market by Demographics
7.4.4.3.3 UAE Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.4.4.4 Saudi Arabia Attention Deficit Hyperactivity Disorder Market
7.4.4.4.1 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Drug Type
7.4.4.4.1.1 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.4.4.4.1.2 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.4.4.4.2 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Demographics
7.4.4.4.3 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.4.4.5 South Africa Attention Deficit Hyperactivity Disorder Market
7.4.4.5.1 South Africa Attention Deficit Hyperactivity Disorder Market by Drug Type
7.4.4.5.1.1 South Africa Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.4.4.5.1.2 South Africa Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.4.4.5.2 South Africa Attention Deficit Hyperactivity Disorder Market by Demographics
7.4.4.5.3 South Africa Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.4.4.6 Nigeria Attention Deficit Hyperactivity Disorder Market
7.4.4.6.1 Nigeria Attention Deficit Hyperactivity Disorder Market by Drug Type
7.4.4.6.1.1 Nigeria Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.4.4.6.1.2 Nigeria Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.4.4.6.2 Nigeria Attention Deficit Hyperactivity Disorder Market by Demographics
7.4.4.6.3 Nigeria Attention Deficit Hyperactivity Disorder Market by Distribution Channel
7.4.4.7 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market
7.4.4.7.1 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Drug Type
7.4.4.7.1.1 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Stimulants Type
7.4.4.7.1.2 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type
7.4.4.7.2 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Demographics
7.4.4.7.3 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Distribution Channel

Chapter 8. Company Profiles
8.1 Eli Lilly And Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.2 Pfizer, Inc. (Global Blood Therapeutics, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expense
8.4 Lupin Limited
8.4.1 Company Overview
8.4.2 Financial Analysis
8.5 Novartis AG
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Approvals and Trials:
8.6 Takeda Pharmaceutical Company Limited
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expense
8.7 Mallinckrodt PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 Purdue Pharma L.P.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Approvals and Trials:
8.9 Aytu BioPharma, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Product Launches and Product Expansions:
8.9.5.2 Approvals and Trials:
8.10. Supernus Pharmaceuticals, Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Research & Development Expenses
8.10.4 Recent strategies and developments:
8.10.4.1 Approvals and Trials:

TABLE 1 Global Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 2 Global Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 3 Global Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 4 Global Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 5 Global Stimulants Market by Region, 2018 - 2021, USD Million
TABLE 6 Global Stimulants Market by Region, 2022 - 2028, USD Million
TABLE 7 Global Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 8 Global Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 9 Global Amphetamine Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Amphetamine Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Methylphenidate Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Methylphenidate Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Lisdexamfetamine Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Lisdexamfetamine Market by Region, 2022 - 2028, USD Million
TABLE 15 Global Dexmethylphenidate Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Dexmethylphenidate Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Non-stimulants Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Non-stimulants Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 20 Global Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 21 Global Atomoxetine Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Atomoxetine Market by Region, 2022 - 2028, USD Million
TABLE 23 Global Guanfacine Market by Region, 2018 - 2021, USD Million
TABLE 24 Global Guanfacine Market by Region, 2022 - 2028, USD Million
TABLE 25 Global Clonidine Market by Region, 2018 - 2021, USD Million
TABLE 26 Global Clonidine Market by Region, 2022 - 2028, USD Million
TABLE 27 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 28 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 29 Global Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 30 Global Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 31 Global Adults Market by Region, 2018 - 2021, USD Million
TABLE 32 Global Adults Market by Region, 2022 - 2028, USD Million
TABLE 33 Global Children Market by Region, 2018 - 2021, USD Million
TABLE 34 Global Children Market by Region, 2022 - 2028, USD Million
TABLE 35 Global Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 36 Global Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 37 Global Retail Pharmacy Market by Region, 2018 - 2021, USD Million
TABLE 38 Global Retail Pharmacy Market by Region, 2022 - 2028, USD Million
TABLE 39 Global Hospital Pharmacy Market by Region, 2018 - 2021, USD Million
TABLE 40 Global Hospital Pharmacy Market by Region, 2022 - 2028, USD Million
TABLE 41 Global Attention Deficit Hyperactivity Disorder Market by Region, 2018 - 2021, USD Million
TABLE 42 Global Attention Deficit Hyperactivity Disorder Market by Region, 2022 - 2028, USD Million
TABLE 43 North America Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 44 North America Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 45 North America Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 46 North America Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 47 North America Stimulants Market by Country, 2018 - 2021, USD Million
TABLE 48 North America Stimulants Market by Country, 2022 - 2028, USD Million
TABLE 49 North America Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 50 North America Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 51 North America Amphetamine Market by Country, 2018 - 2021, USD Million
TABLE 52 North America Amphetamine Market by Country, 2022 - 2028, USD Million
TABLE 53 North America Methylphenidate Market by Country, 2018 - 2021, USD Million
TABLE 54 North America Methylphenidate Market by Country, 2022 - 2028, USD Million
TABLE 55 North America Lisdexamfetamine Market by Country, 2018 - 2021, USD Million
TABLE 56 North America Lisdexamfetamine Market by Country, 2022 - 2028, USD Million
TABLE 57 North America Dexmethylphenidate Market by Country, 2018 - 2021, USD Million
TABLE 58 North America Dexmethylphenidate Market by Country, 2022 - 2028, USD Million
TABLE 59 North America Non-stimulants Market by Country, 2018 - 2021, USD Million
TABLE 60 North America Non-stimulants Market by Country, 2022 - 2028, USD Million
TABLE 61 North America Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 62 North America Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 63 North America Atomoxetine Market by Country, 2018 - 2021, USD Million
TABLE 64 North America Atomoxetine Market by Country, 2022 - 2028, USD Million
TABLE 65 North America Guanfacine Market by Country, 2018 - 2021, USD Million
TABLE 66 North America Guanfacine Market by Country, 2022 - 2028, USD Million
TABLE 67 North America Clonidine Market by Country, 2018 - 2021, USD Million
TABLE 68 North America Clonidine Market by Country, 2022 - 2028, USD Million
TABLE 69 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 70 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 71 North America Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 72 North America Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 73 North America Adults Market by Country, 2018 - 2021, USD Million
TABLE 74 North America Adults Market by Country, 2022 - 2028, USD Million
TABLE 75 North America Children Market by Country, 2018 - 2021, USD Million
TABLE 76 North America Children Market by Country, 2022 - 2028, USD Million
TABLE 77 North America Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 78 North America Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 79 North America Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 80 North America Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 81 North America Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 82 North America Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 83 North America Attention Deficit Hyperactivity Disorder Market by Country, 2018 - 2021, USD Million
TABLE 84 North America Attention Deficit Hyperactivity Disorder Market by Country, 2022 - 2028, USD Million
TABLE 85 US Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 86 US Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 87 US Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 88 US Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 89 US Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 90 US Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 91 US Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 92 US Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 93 US Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 94 US Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 95 US Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 96 US Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 97 Canada Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 98 Canada Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 99 Canada Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 100 Canada Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 101 Canada Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 102 Canada Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 103 Canada Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 104 Canada Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 105 Canada Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 106 Canada Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 107 Canada Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 108 Canada Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 109 Mexico Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 110 Mexico Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 111 Mexico Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 112 Mexico Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 113 Mexico Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 114 Mexico Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 115 Mexico Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 116 Mexico Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 117 Mexico Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 118 Mexico Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 119 Mexico Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 120 Mexico Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 121 Rest of North America Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 122 Rest of North America Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 123 Rest of North America Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 124 Rest of North America Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 125 Rest of North America Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 126 Rest of North America Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 127 Rest of North America Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 128 Rest of North America Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 129 Rest of North America Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 130 Rest of North America Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 131 Rest of North America Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 132 Rest of North America Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 133 Europe Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 134 Europe Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 135 Europe Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 136 Europe Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 137 Europe Stimulants Market by Country, 2018 - 2021, USD Million
TABLE 138 Europe Stimulants Market by Country, 2022 - 2028, USD Million
TABLE 139 Europe Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 140 Europe Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 141 Europe Amphetamine Market by Country, 2018 - 2021, USD Million
TABLE 142 Europe Amphetamine Market by Country, 2022 - 2028, USD Million
TABLE 143 Europe Methylphenidate Market by Country, 2018 - 2021, USD Million
TABLE 144 Europe Methylphenidate Market by Country, 2022 - 2028, USD Million
TABLE 145 Europe Lisdexamfetamine Market by Country, 2018 - 2021, USD Million
TABLE 146 Europe Lisdexamfetamine Market by Country, 2022 - 2028, USD Million
TABLE 147 Europe Dexmethylphenidate Market by Country, 2018 - 2021, USD Million
TABLE 148 Europe Dexmethylphenidate Market by Country, 2022 - 2028, USD Million
TABLE 149 Europe Non-stimulants Market by Country, 2018 - 2021, USD Million
TABLE 150 Europe Non-stimulants Market by Country, 2022 - 2028, USD Million
TABLE 151 Europe Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 152 Europe Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 153 Europe Atomoxetine Market by Country, 2018 - 2021, USD Million
TABLE 154 Europe Atomoxetine Market by Country, 2022 - 2028, USD Million
TABLE 155 Europe Guanfacine Market by Country, 2018 - 2021, USD Million
TABLE 156 Europe Guanfacine Market by Country, 2022 - 2028, USD Million
TABLE 157 Europe Clonidine Market by Country, 2018 - 2021, USD Million
TABLE 158 Europe Clonidine Market by Country, 2022 - 2028, USD Million
TABLE 159 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 160 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 161 Europe Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 162 Europe Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 163 Europe Adults Market by Country, 2018 - 2021, USD Million
TABLE 164 Europe Adults Market by Country, 2022 - 2028, USD Million
TABLE 165 Europe Children Market by Country, 2018 - 2021, USD Million
TABLE 166 Europe Children Market by Country, 2022 - 2028, USD Million
TABLE 167 Europe Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 168 Europe Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 169 Europe Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 170 Europe Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 171 Europe Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 172 Europe Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 173 Europe Attention Deficit Hyperactivity Disorder Market by Country, 2018 - 2021, USD Million
TABLE 174 Europe Attention Deficit Hyperactivity Disorder Market by Country, 2022 - 2028, USD Million
TABLE 175 Germany Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 176 Germany Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 177 Germany Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 178 Germany Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 179 Germany Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 180 Germany Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 181 Germany Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 182 Germany Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 183 Germany Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 184 Germany Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 185 Germany Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 186 Germany Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 187 UK Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 188 UK Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 189 UK Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 190 UK Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 191 UK Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 192 UK Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 193 UK Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 194 UK Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 195 UK Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 196 UK Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 197 UK Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 198 UK Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 199 France Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 200 France Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 201 France Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 202 France Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 203 France Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 204 France Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 205 France Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 206 France Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 207 France Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 208 France Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 209 France Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 210 France Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 211 Russia Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 212 Russia Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 213 Russia Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 214 Russia Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 215 Russia Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 216 Russia Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 217 Russia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 218 Russia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 219 Russia Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 220 Russia Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 221 Russia Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 222 Russia Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 223 Spain Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 224 Spain Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 225 Spain Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 226 Spain Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 227 Spain Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 228 Spain Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 229 Spain Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 230 Spain Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 231 Spain Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 232 Spain Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 233 Spain Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 234 Spain Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 235 Italy Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 236 Italy Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 237 Italy Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 238 Italy Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 239 Italy Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 240 Italy Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 241 Italy Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 242 Italy Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 243 Italy Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 244 Italy Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 245 Italy Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 246 Italy Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 247 Rest of Europe Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 248 Rest of Europe Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 249 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 250 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 251 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 252 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 253 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 254 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 255 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 256 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 257 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 258 Rest of Europe Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 259 Asia Pacific Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 260 Asia Pacific Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 261 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 262 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 263 Asia Pacific Stimulants Market by Country, 2018 - 2021, USD Million
TABLE 264 Asia Pacific Stimulants Market by Country, 2022 - 2028, USD Million
TABLE 265 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 266 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 267 Asia Pacific Amphetamine Market by Country, 2018 - 2021, USD Million
TABLE 268 Asia Pacific Amphetamine Market by Country, 2022 - 2028, USD Million
TABLE 269 Asia Pacific Methylphenidate Market by Country, 2018 - 2021, USD Million
TABLE 270 Asia Pacific Methylphenidate Market by Country, 2022 - 2028, USD Million
TABLE 271 Asia Pacific Lisdexamfetamine Market by Country, 2018 - 2021, USD Million
TABLE 272 Asia Pacific Lisdexamfetamine Market by Country, 2022 - 2028, USD Million
TABLE 273 Asia Pacific Dexmethylphenidate Market by Country, 2018 - 2021, USD Million
TABLE 274 Asia Pacific Dexmethylphenidate Market by Country, 2022 - 2028, USD Million
TABLE 275 Asia Pacific Non-stimulants Market by Country, 2018 - 2021, USD Million
TABLE 276 Asia Pacific Non-stimulants Market by Country, 2022 - 2028, USD Million
TABLE 277 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 278 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 279 Asia Pacific Atomoxetine Market by Country, 2018 - 2021, USD Million
TABLE 280 Asia Pacific Atomoxetine Market by Country, 2022 - 2028, USD Million
TABLE 281 Asia Pacific Guanfacine Market by Country, 2018 - 2021, USD Million
TABLE 282 Asia Pacific Guanfacine Market by Country, 2022 - 2028, USD Million
TABLE 283 Asia Pacific Clonidine Market by Country, 2018 - 2021, USD Million
TABLE 284 Asia Pacific Clonidine Market by Country, 2022 - 2028, USD Million
TABLE 285 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 286 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 287 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 288 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 289 Asia Pacific Adults Market by Country, 2018 - 2021, USD Million
TABLE 290 Asia Pacific Adults Market by Country, 2022 - 2028, USD Million
TABLE 291 Asia Pacific Children Market by Country, 2018 - 2021, USD Million
TABLE 292 Asia Pacific Children Market by Country, 2022 - 2028, USD Million
TABLE 293 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 294 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 295 Asia Pacific Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 296 Asia Pacific Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 297 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 298 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 299 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Country, 2018 - 2021, USD Million
TABLE 300 Asia Pacific Attention Deficit Hyperactivity Disorder Market by Country, 2022 - 2028, USD Million
TABLE 301 China Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 302 China Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 303 China Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 304 China Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 305 China Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 306 China Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 307 China Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 308 China Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 309 China Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 310 China Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 311 China Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 312 China Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 313 Japan Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 314 Japan Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 315 Japan Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 316 Japan Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 317 Japan Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 318 Japan Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 319 Japan Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 320 Japan Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 321 Japan Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 322 Japan Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 323 Japan Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 324 Japan Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 325 India Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 326 India Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 327 India Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 328 India Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 329 India Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 330 India Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 331 India Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 332 India Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 333 India Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 334 India Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 335 India Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 336 India Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 337 South Korea Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 338 South Korea Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 339 South Korea Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 340 South Korea Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 341 South Korea Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 342 South Korea Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 343 South Korea Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 344 South Korea Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 345 South Korea Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 346 South Korea Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 347 South Korea Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 348 South Korea Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 349 Singapore Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 350 Singapore Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 351 Singapore Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 352 Singapore Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 353 Singapore Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 354 Singapore Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 355 Singapore Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 356 Singapore Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 357 Singapore Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 358 Singapore Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 359 Singapore Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 360 Singapore Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 361 Malaysia Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 362 Malaysia Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 363 Malaysia Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 364 Malaysia Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 365 Malaysia Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 366 Malaysia Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 367 Malaysia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 368 Malaysia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 369 Malaysia Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 370 Malaysia Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 371 Malaysia Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 372 Malaysia Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 373 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 374 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 375 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 376 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 377 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 378 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 379 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 380 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 381 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 382 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 383 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 384 Rest of Asia Pacific Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 385 LAMEA Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 386 LAMEA Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 387 LAMEA Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 388 LAMEA Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 389 LAMEA Stimulants Market by Country, 2018 - 2021, USD Million
TABLE 390 LAMEA Stimulants Market by Country, 2022 - 2028, USD Million
TABLE 391 LAMEA Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 392 LAMEA Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 393 LAMEA Amphetamine Market by Country, 2018 - 2021, USD Million
TABLE 394 LAMEA Amphetamine Market by Country, 2022 - 2028, USD Million
TABLE 395 LAMEA Methylphenidate Market by Country, 2018 - 2021, USD Million
TABLE 396 LAMEA Methylphenidate Market by Country, 2022 - 2028, USD Million
TABLE 397 LAMEA Lisdexamfetamine Market by Country, 2018 - 2021, USD Million
TABLE 398 LAMEA Lisdexamfetamine Market by Country, 2022 - 2028, USD Million
TABLE 399 LAMEA Dexmethylphenidate Market by Country, 2018 - 2021, USD Million
TABLE 400 LAMEA Dexmethylphenidate Market by Country, 2022 - 2028, USD Million
TABLE 401 LAMEA Non-stimulants Market by Country, 2018 - 2021, USD Million
TABLE 402 LAMEA Non-stimulants Market by Country, 2022 - 2028, USD Million
TABLE 403 LAMEA Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 404 LAMEA Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 405 LAMEA Atomoxetine Market by Country, 2018 - 2021, USD Million
TABLE 406 LAMEA Atomoxetine Market by Country, 2022 - 2028, USD Million
TABLE 407 LAMEA Guanfacine Market by Country, 2018 - 2021, USD Million
TABLE 408 LAMEA Guanfacine Market by Country, 2022 - 2028, USD Million
TABLE 409 LAMEA Clonidine Market by Country, 2018 - 2021, USD Million
TABLE 410 LAMEA Clonidine Market by Country, 2022 - 2028, USD Million
TABLE 411 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 412 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 413 LAMEA Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 414 LAMEA Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 415 LAMEA Adults Market by Country, 2018 - 2021, USD Million
TABLE 416 LAMEA Adults Market by Country, 2022 - 2028, USD Million
TABLE 417 LAMEA Children Market by Country, 2018 - 2021, USD Million
TABLE 418 LAMEA Children Market by Country, 2022 - 2028, USD Million
TABLE 419 LAMEA Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 420 LAMEA Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 421 LAMEA Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 422 LAMEA Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 423 LAMEA Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 424 LAMEA Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 425 LAMEA Attention Deficit Hyperactivity Disorder Market by Country, 2018 - 2021, USD Million
TABLE 426 LAMEA Attention Deficit Hyperactivity Disorder Market by Country, 2022 - 2028, USD Million
TABLE 427 Brazil Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 428 Brazil Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 429 Brazil Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 430 Brazil Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 431 Brazil Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 432 Brazil Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 433 Brazil Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 434 Brazil Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 435 Brazil Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 436 Brazil Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 437 Brazil Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 438 Brazil Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 439 Argentina Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 440 Argentina Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 441 Argentina Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 442 Argentina Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 443 Argentina Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 444 Argentina Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 445 Argentina Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 446 Argentina Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 447 Argentina Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 448 Argentina Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 449 Argentina Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 450 Argentina Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 451 UAE Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 452 UAE Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 453 UAE Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 454 UAE Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 455 UAE Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 456 UAE Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 457 UAE Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 458 UAE Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 459 UAE Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 460 UAE Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 461 UAE Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 462 UAE Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 463 Saudi Arabia Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 464 Saudi Arabia Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 465 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 466 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 467 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 468 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 469 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 470 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 471 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 472 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 473 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 474 Saudi Arabia Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 475 South Africa Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 476 South Africa Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 477 South Africa Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 478 South Africa Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 479 South Africa Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 480 South Africa Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 481 South Africa Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 482 South Africa Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 483 South Africa Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 484 South Africa Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 485 South Africa Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 486 South Africa Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 487 Nigeria Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 488 Nigeria Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 489 Nigeria Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 490 Nigeria Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 491 Nigeria Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 492 Nigeria Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 493 Nigeria Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 494 Nigeria Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 495 Nigeria Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 496 Nigeria Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 497 Nigeria Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 498 Nigeria Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 499 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market, 2018 - 2021, USD Million
TABLE 500 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market, 2022 - 2028, USD Million
TABLE 501 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2021, USD Million
TABLE 502 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Drug Type, 2022 - 2028, USD Million
TABLE 503 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2018 - 2021, USD Million
TABLE 504 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Stimulants Type, 2022 - 2028, USD Million
TABLE 505 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2018 - 2021, USD Million
TABLE 506 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Non-stimulants Type, 2022 - 2028, USD Million
TABLE 507 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2021, USD Million
TABLE 508 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Demographics, 2022 - 2028, USD Million
TABLE 509 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 510 Rest of LAMEA Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 511 Key Information – Eli Lilly And Company
TABLE 512 Key Information – Pfizer, Inc.
TABLE 513 Key Information – Johnson & Johnson (Johnson & Johnson Services, Inc.)
TABLE 514 Key Information – Lupin Limited
TABLE 515 Key Information – Novartis AG
TABLE 516 Key Information – Takeda Pharmaceutical Company Limited
TABLE 517 Key information – Mallinckrodt PLC
TABLE 518 Key Information – Purdue Pharma L.P.
TABLE 519 Key Information – AYTU BIOPHARMA, INC.
TABLE 520 Key Information – Supernus Pharmaceuticals, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Global Attention Deficit Hyperactivity Disorder Market Share by Drug Type, 2021
FIG 3 Global Attention Deficit Hyperactivity Disorder Market Share by Drug Type, 2028
FIG 4 Global Attention Deficit Hyperactivity Disorder Market by Drug Type, 2018 - 2028, USD Million
FIG 5 Global Attention Deficit Hyperactivity Disorder Market Share by Demographics, 2021
FIG 6 Global Attention Deficit Hyperactivity Disorder Market Share by Demographics, 2028
FIG 7 Global Attention Deficit Hyperactivity Disorder Market by Demographics, 2018 - 2028, USD Million
FIG 8 Global Attention Deficit Hyperactivity Disorder Market Share by Distribution Channel, 2021
FIG 9 Global Attention Deficit Hyperactivity Disorder Market Share by Distribution Channel, 2028
FIG 10 Global Attention Deficit Hyperactivity Disorder Market by Distribution Channel, 2018 - 2028, USD Million
FIG 11 Global Attention Deficit Hyperactivity Disorder Market Share by Region, 2021
FIG 12 Global Attention Deficit Hyperactivity Disorder Market Share by Region, 2028
FIG 13 Global Attention Deficit Hyperactivity Disorder Market by Region, 2018 - 2028, USD Millione